ASX:EMV

EMvision Medical Devices Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume192,157 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive EMV News and Ratings via Email

Sign-up to receive the latest news and ratings for EMvision Medical Devices and its competitors with MarketBeat's FREE daily newsletter.

About EMvision Medical Devices

EMvision Medical Devices Limited engages in the research, development, and commercialization of imaging and diagnostic technology for the purpose of commercializing portable medical device for stroke diagnosis and monitoring, and other medical imaging needs. The company has a strategic collaboration with Keysight Technologies Malaysia Sdn Bhd to develop a personalized vector network analysis solution for medical imaging in the healthcare sector. EMvision Medical Devices Limited was founded in 2017 and is based in Macquarie Park, Australia.

Is EMvision Medical Devices' (ASX:EMV) Share Price Gain Of 227% Well Earned?
May 16, 2021 | finance.yahoo.com

Brain And Neuroimaging Devices Global Market Report 2021: COVID 19 Growth And Change to 2030
May 10, 2021 | uk.finance.yahoo.com

The EMVision (ASX:EMV) share price jumped today. Here’s why
April 28, 2021 | msn.com

EMVision says it’s developing better stroke-detecting technology
April 27, 2021 | msn.com

As health tech soars, these two ASX medical device plays might have flown under the radar
April 27, 2021 | msn.com

Why is the EMvision (ASX:EMV) share price surging 12% this week?
April 16, 2021 | msn.com

Why the EMvision (ASX: EMV) share price closed 13% higher today
March 2, 2021 | msn.com

Why the EMvision (ASX:EMV) share price is going nowhere
March 1, 2021 | msn.com

We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
February 15, 2021 | finance.yahoo.com

EMvision Medical Devices Ltd.
January 27, 2021 | barrons.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange ASX
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolASX:EMV
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.emvision.com.au
Phone61 2 8667 5337
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual Sales$2.07 million
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow8.47
Book ValueA$0.18 per share
Price / BookN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.86 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for EMvision Medical Devices.

4.3 Community Rank

Outperform Votes
EMvision Medical Devices has received 102 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
EMvision Medical Devices has received 16 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
EMvision Medical Devices has received 86.44% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about EMvision Medical Devices and other stocks. Vote “Outperform” if you believe EMV will outperform the S&P 500 over the long term. Vote “Underperform” if you believe EMV will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
EMvision Medical Devices does not currently pay a dividend.
Dividend Growth
EMvision Medical Devices does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, EMvision Medical Devices insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

EMvision Medical Devices (ASX:EMV) Frequently Asked Questions

What stocks does MarketBeat like better than EMvision Medical Devices?

Wall Street analysts have given EMvision Medical Devices a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but EMvision Medical Devices wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were EMvision Medical Devices' earnings last quarter?

EMvision Medical Devices Limited (ASX:EMV) posted its quarterly earnings results on Tuesday, February, 26th. The company reported ($4.47) EPS for the quarter.
View EMvision Medical Devices' earnings history.

Who are EMvision Medical Devices' key executives?

EMvision Medical Devices' management team includes the following people:

Dr. Ronald Peter Weinberger, CEO, MD & Director
Mr. Scott Kirkland, Exec. Director
Ms. Emma Waldon, CFO & Company Sec. (Age 45)
Dr. Konstanty Bialkowski, Head of Technology Devel.
Prof. Stuart Crozier B.E., M.Sc., Ph.D., Chairman of Clinical Advisory Board & Chief Scientific Officer
Mr. Robert Tiller, Head of Design
Ms. Ruth Cremin, Head of Quality & Regulatory Affairs
Ms. Forough Khandan, Head of Program Management

Who are some of EMvision Medical Devices' key competitors?

Some companies that are related to EMvision Medical Devices include 4DMedical (4DX), Adherium (ADR), ADM Tronics Unlimited (ADMT), Allegra Orthopaedics (AMT), Analytica (ALT), AnteoTech (ADO), Anteris Technologies (AVR), Asensus Surgical (ASXC), Atomo Diagnostics (AT1), AVITA Medical (AVH), Azure Healthcare Limited (AZV.AX) (AZV), Cannabix Technologies (BLO), CleanSpace (CSX), Cochlear (COH) and Cochlear (CHEOY).
View all of EMV's competitors.

What is EMvision Medical Devices' stock symbol?

EMvision Medical Devices trades on the ASX under the ticker symbol "EMV."

How much money does EMvision Medical Devices make?

EMvision Medical Devices has a market capitalization of $0.00 and generates $2.07 million in revenue each year.

What is EMvision Medical Devices' official website?

The official website for EMvision Medical Devices is www.emvision.com.au.

How can I contact EMvision Medical Devices?

The company can be reached via phone at 61 2 8667 5337.

This page was last updated on 7/27/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.